Prediction of Anxiety and Memory State

CAMERA will record neural, physiological, behavioral, and environmental signals, as well as measurements from ecological momentary assessments (EMAs), to develop a continuous high-resolution prediction of a person's level of anxiety and cognitive performance. CAMERA will provide a significant advance over current methods for human behavioral measurement because it leverages the complementary features of multimodal data sources and combines them with interpretable machine learning to predict human behavior. A further distinctive aspect of CAMERA is that it incorporates context-aware, adaptive EMA, where the timing of assessments depends on the subject's physiology and behavior to improve response rates and model learning. In this study, CAMERA focuses on predicting anxiety state and concurrent memory performance, but the platform is flexible for use in various domains.

Currently, it is challenging to study complex, longitudinal relationships between the brain, body, and environment in humans. Most existent tools do not allow the investigator to measure transient internal states or cognitive functions comprehensively or continuously. Instead the investigators typically rely on sparsely collected and constrained self-reports or experimental constructs, including EMA.

Inclusion criteria

• Patients must have known or suspected Temporal Lobe Epilepsy.
• Native or proficient in speaking English or Spanish.
• Stereoelectroencephalography (sEEG) cases: The implant plan must include hippocampal head, body, and tail electrodes either unilaterally or bilaterally.
• 7th grade reading level (minimum level considered literate for adults)

Exclusion criteria

• Hearing impaired (i.e., not corrected with a hearing aid)
• Unable to read the newspaper at arm's length with corrective lenses.
• Objective intellectual impairment (estimated IQ < 70)
• Any history of Electroconvulsive Therapy or psychosis (except postictal psychosis for patients)
• Psychotic disorder (lifetime)
• Current Anxiety disorder, Major Depressive Disorder, or Bipolar Disorder
• Neurodegenerative diseases, presence of widespread brain lesions, language problems (other than naming difficulty)
• Medical conditions that could potentially affect cognitive performance (e.g., human immunodeficiency virus (HIV) infection, cancer with metastatic potential).
• Acute renal failure or end-stage renal disease